L01X Other antineoplastic agents
ATC group of level 3 – pharmacological subgroup · in plain English: cancer medicines
This site has the patient leaflet or the SPC of 225 medicines in this group and its subgroups.
- 132 prescription only (POM)
- 14 no longer supplied or not available
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
-
L01X Other antineoplastic agents 225 medicines
- L01XA Platinum compounds, antineoplastic drugs 11 medicines
- L01XB Methylhydrazines, antineoplastics 1 medicine
- L01XC Monoclonal antibodies, antineoplastic 73 medicines
- L01XD Sensitizers used in photodynamic/radiation therapy 10 medicines
- L01XF Retinoids for cancer treatment 2 medicines
- L01XG Proteasome inhibitors, antineoplastic agent 43 medicines
- L01XH Histone deacetylase (HDAC) inhibitors 3 medicines
- L01XJ Hedgehog pathway inhibitors 4 medicines
- L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors 13 medicines
- L01XX Other antineoplastic agents 59 medicines
- L01XY Combinations of antineoplastic agents 4 medicines
-
L01X Other antineoplastic agents 225 medicines
- L01 Antineoplastic agents 1,025 medicines
Active substances in the group
- Aflibercept 1 medicine
- Aminolevulinic acid hydrochloride 4 medicines
- Amivantamab 1 medicine
- Amsacrine 1 medicine
- Anagrelide 13 medicines
- Arsenic 6 medicines
- Arsenic trioxide 1 medicine
- Asparaginase 1 medicine
- Atezolizumab 1 medicine
- Avelumab 1 medicine
- Axicabtagene ciloleucel 1 medicine
- Belantamab mafodotin 2 medicines
- Bevacizumab 12 medicines
- Bexarotene 2 medicines
- Blinatumomab 2 medicines
- Bortezomib 33 medicines
- Brentuximab vedotin 1 medicine
- Brexucabtagene autoleucel 1 medicine
- Carboplatin 3 medicines
- Carfilzomib 4 medicines
- Catumaxomab 1 medicine
- Celecoxib 1 medicine
- Cemiplimab 1 medicine
- Cetuximab 1 medicine
- Cisplatin 3 medicines
- Crisantaspase 2 medicines
- Cytarabine (liposomal) 1 medicine
- Daratumumab 2 medicines
- Daunorubicin (liposomal) 1 medicine
- Daunorubicin hydrochloride, cytarabine 1 medicine
- Dinutuximab 1 medicine
- Dinutuximab beta 2 medicines
- Dostarlimab 1 medicine
- Durvalumab 1 medicine
- Eribulin 6 medicines
- Gemtuzumab ozogamicin 1 medicine
- Glasdegib 2 medicines
- Hydroxycarbamide 9 medicines
- Inotuzumab ozogamicin 1 medicine
- Ipilimumab 1 medicine
- Isatuximab 1 medicine
- Ixazomib 6 medicines
- Methyl aminolevulinate 1 medicine
- Mitotane 3 medicines
- Mogamulizumab 1 medicine
- Moxetumomab pasudotox 1 medicine
- Niraparib 2 medicines
- Nivolumab 2 medicines
- Obinutuzumab 1 medicine
- Ofatumumab 1 medicine
- Olaparib 3 medicines
- Olaratumab 1 medicine
- Oxaliplatin 5 medicines
- Padeliporfin di-potassium 2 medicines
- Panitumumab 1 medicine
- Panobinostat 3 medicines
- Pegaspargase 3 medicines
- Pentostatin 1 medicine
- Pertuzumab 3 medicines
- Polatuzumab vedotin 1 medicine
- Porfimer 2 medicines
- Procarbazine 1 medicine
- Ramucirumab 1 medicine
- Rituximab 10 medicines
- Rucaparib 3 medicines
- Sacituzumab govitecan 1 medicine
- Selinexor 1 medicine
- Sonidegib diphosphate 1 medicine
- Tafasitamab 1 medicine
- Tagraxofusp 1 medicine
- Talazoparib 5 medicines
- Talimogene laherparepvec 3 medicines
- Temoporfin 1 medicine
- Tisagenlecleucel 1 medicine
- Trastuzumab 16 medicines
- Trastuzumab deruxtecan 1 medicine
- Trastuzumab emtansine 2 medicines
- Venetoclax 3 medicines
- Vismodegib 1 medicine
Medicines in the group and its subgroups
Other groups of the same level
- L01A Alkylating agents 123 medicines
- L01B Antimetabolites 182 medicines
- L01C Plant alkaloids and other natural products, antineoplastic drugs 97 medicines
- L01D Cytotoxic antibiotics and related substances 42 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
Other names of the ATC group
- Czech: L01X Jiná cytostatika
- French: L01X autres antinéoplasiques
- German: L01X Andere antineoplastische Mittel
- Spanish: L01X Otros antineoplasicos
- German: L01X Andere antineoplastische Mittel
- Italian: L01X ALTRI ANTINEOPLASTICI
- Polish: L01X Inne cytostatyki
- Turkish: L01X ATC'DEKİ DİĞER ANTİNEOPLASTİK AJANLAR
- Portuguese (Brazil): L01X OUTROS AGENTES ANTI-NEOPLÁSICOS
- Slovak: L01X Iné cytostatiká
- German (Switzerland): L01X Andere antineoplastische Mittel
- French (Switzerland): L01X Autres antinéoplasiques
- Italian (Switzerland): L01X Altri antineoplastici
- Dutch: L01X Overige oncolytica
- English (Canada): L01X Other antineoplastic agents
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01X
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
